Combinatorial Polydopamine-Liposome Nanoformulation as an Effective Anti-Breast Cancer Therapy
International Journal of Nanomedicine · 2023
DOI: 10.2147/ijn.s382109 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2023. Verfasst von Wangxing Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410000, People's Republic of China. Hauptthemen laut MEDLINE: Breast Neoplasms, Nanoparticles. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410000, People's Republic of China.
- School of Basic Medical Science, Central South University, Changsha, 410000, People's Republic of China.
ORCID-Profile: Anna Hu
Zitieren
APA
Lu, W., Liu, W., Hu, A., Shen, J., Yi, H., & Cheng, Z. (2023). Combinatorial Polydopamine-Liposome Nanoformulation as an Effective Anti-Breast Cancer Therapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s382109
Vancouver
Lu W, Liu W, Hu A, Shen J, Yi H, Cheng Z. Combinatorial Polydopamine-Liposome Nanoformulation as an Effective Anti-Breast Cancer Therapy. International Journal of Nanomedicine. 2023. doi:10.2147/ijn.s382109
BibTeX
@article{Lu2023,
author = {Lu, Wangxing and Liu, Wenjie and Hu, Anna and Shen, Jian and Yi, Hanxi and Cheng, Zeneng},
title = {Combinatorial Polydopamine-Liposome Nanoformulation as an Effective Anti-Breast Cancer Therapy},
journal = {International Journal of Nanomedicine},
year = {2023},
doi = {10.2147/ijn.s382109}
}
EUVIMED